March 29 (Reuters) - HEALTH CANADA:
* HEALTH CANADA TAKING FURTHER ACTION TO CONFIRM BENEFIT-RISK PROFILE OF ASTRAZENECA VACCINE
* HEALTH CANADA - WILL BE ISSUING ADDITIONAL TERMS AND CONDITIONS ON AUTHORIZATIONS OF ASTRAZENECA & VERITY PHARMA/SERUM INSTITUTE OF INDIA VACCINES
* HEALTH CANADA-TO ADD REQUIREMENT THAT ASTRAZENECA COVID-19 VACCINE MAKERS CONDUCT DETAILED ASSESSMENT OF BENEFITS-RISK BY AGE, SEX IN CANADIAN CONTEXT